Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAlloVir Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
AlloVir Inc Earnings Date And Information
AlloVir Inc last posted its earnings results on Tuesday, March 17th, 2026. The company reported $-1.6 earnings per share for the quarter, topping analysts' consensus estimates of $-4.37 by $2.77. The company had revenue of 0 for the quarter and had revenue of 0 for the year. AlloVir Inc has generated $-3 earnings per share over the last year ($-2.85 diluted earnings per share) and currently has a price-to-earnings ratio of -2.67. AlloVir Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
AlloVir Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/17/2026 | Q4 2025 | -$4.37 | -$1.60 | 2.77 | $0 | $0 |
| 11/12/2025 | Q3 2025 | N/A | -$0.64 | N/A | N/A | $0 |
| 08/13/2025 | Q2 2025 | N/A | -$0.61 | N/A | N/A | $0 |
| 05/14/2025 | Q1 2025 | N/A | $0.00 | N/A | N/A | $0 |
| 03/07/2025 | Q4 2024 | -$2.76 | -$3.68 | -0.92 | $0 | $0 |
| 11/12/2024 | Q3 2024 | -$3.22 | -$0.82 | 2.4 | $0 | $0 |
| 08/09/2024 | Q2 2024 | -$2.30 | -$1.21 | 1.09 | $0 | $0 |
| 05/13/2024 | Q1 2024 | -$3.68 | -$5.98 | -2.3 | N/A | $0 |
| 03/15/2024 | Q4 2023 | -$9.89 | -$11.96 | -2.07 | N/A | $8.38 M |
| 11/02/2023 | Q3 2023 | -$9.66 | -$8.97 | 0.69 | N/A | $0 |
| 08/03/2023 | Q2 2023 | -$10.34 | -$11.04 | -0.7 | N/A | $0 |
| 05/04/2023 | Q1 2023 | -$10.80 | -$10.12 | 0.68 | N/A | $0 |
| 02/15/2023 | Q4 2022 | -$11.72 | -$9.43 | 2.29 | N/A | $0 |
| 11/03/2022 | Q3 2022 | -$11.95 | -$11.50 | 0.45 | N/A | $0 |
| 08/04/2022 | Q2 2022 | -$16.09 | -$15.87 | 0.22 | N/A | $0 |
| 05/05/2022 | Q1 2022 | -$17.01 | -$15.87 | 1.14 | N/A | $0 |
| 02/10/2022 | Q4 2021 | -$16.32 | -$20.93 | -4.61 | N/A | $0 |
| 11/05/2021 | Q3 2021 | -$13.56 | -$16.56 | -3 | N/A | $0 |
| 08/06/2021 | Q2 2021 | -$10.57 | -$13.80 | -3.23 | N/A | $0 |
| 05/06/2021 | Q1 2021 | -$9.20 | -$11.50 | -2.3 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
AlloVir Inc Earnings: FAQ's
In the previous quarter, AlloVir Inc (:ALVR) reported $-1.6 earnings per share (EPS) to beat the analysts' consensus estimate of $-4.37 by $2.77.
The conference call for AlloVir Inc's latest earnings report can be listened to online.
The conference call transcript for AlloVir Inc's latest earnings report can be read online.
AlloVir Inc (:ALVR) has a recorded net income of $-43,438,000.AlloVir Inc has generated $-2.85 earnings per share over the last four quarters.
AlloVir Inc (:ALVR) has a price-to-earnings ratio of -2.67 and price/earnings-to-growth ratio is -0.03.